12th Swiss Course on Medicinal Chemistry 2016

This five-day Medicinal Chemistry School, that is organized by the Division of Medicinal Chemistry and Chemical Biology of the SCS, will focus on most modern aspects associated with small molecule drug discovery.

Focus on most modern aspects associated with small molecule drug discovery, highlighting the relevance of hit generation, lead finding and lead optimization technologies.

Full Program, 12th Swiss Course on Medicinal Chemistry 2016

Confirmed Speakers:

• Peter Grootenhuis, Vertex, San Diego, US, «Cystis Fibrosis Drug Discovery»
• Jonathan Mason, Heptares, Welwyn Garden City, UK, «Fragment-Based Lead Generation for GPCR modulators»
• Nicholas Meanwell, Bristol-Myers Squibb, Princeton, US, «tactical application of bioisosteres in Lead Optimization»
• Gerhard Klebe, University of Marburg, Germany, «the energetics of ligand-protein interactions»
• Chun Wa Chung, GlaxoSmithKline, Stevenage, UK, «drug discovery projects in the epigenetic target space»

Contact:

Dr. Gerhard Müller, Mercachem B.V.
Dr. Katarzyna Borsuk, Mercachem B.V.